疏肝化瘀解毒法治疗慢性乙型肝炎的临床的的研究

《疏肝化瘀解毒法治疗慢性乙型肝炎的临床的的研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、AbstractAbs仃actobjeetive：ThisresearchaimstoobservetheclinicalefficacyofChronicHepatitisBTreatedwithSoothingtheLiver，RemovingBloodStasisandDetoxifying．TobeconstructedwiththetherapygroupusedwesternmedicineLamivudineorAdefovirDipivoxil．Wewanttoevaluatethetherapeut

2、iceffectandsecurity、析mthemethodofSoothingtheLiver,RemovingBloodStasisandDetoxifyingtreatingChronicHepatitisB，probingintotheeffectinarrestingtheprogressofChronicHepatitisB．Method：57patientswillbeinvolvedfromtheclinicandinpatient，whowillbeseparatedintothetreatmen

3、tgroup(n=29)andthecontrolgroup(n=28)．ThetreatmentgroupadoptedthedecoctionofherbalmedicineofSoothingtheLiver，RemovingBloodStasisandDetoxifying，whilethecontrolgroupwerereceivedLamivudineorAdefovirDipivoxil．Bothoftwogroupsweretreatedfor6months．Theclinicalsymptomsa

4、ndphysicalsigns，integralofTCMsymptoms，Liverfunction，MarkingthingofhepatitisB，Secondliver5ration，HBV-DNAration．changesintheultrasoundindicesofliverandspleenandsafetyindexesweremeasuredrespectivelybeforelreatment,at3monthsandat6months，comparingthetwodifferentther

5、apies．Result：1．Comparisonofthetotalclinicaleffect：Aftertwogroupsweretreatedfor6months，wehavefoundthefollowingresults：ofthetreatinggroup(29cases)，completeresponsewas4cases(13．8％)，partialresponseWaS9cases(31．O％)，non—responsewas16cases(55．2％)，totalefficiencyrateWa

6、s44．8％；Ofthecontrolgroup(28cases)，completeresponsewas8cases(28．6％)，partialresponseWaS12cases(42．9％),nonresponseWas8cases(28．5％)，totalratewas71．4％．ThetreatmentgroupWaSmuchbetterthanthecontrolgroup(P<0．05)．2．Comparisonofimprovementoftheclinicalsymptoms：Thetreatme

7、ntgroupcouldmakethetirednessandinertia,bittertaste，andpoorfeedingbetter(P

8、alueWas79．3％；Ofthecontrolgroup(28cases)，3casesgotclinicalcure，3casesgottherateofeffect，10casesgotvalid，12casesWasinvoid，andthetotaleffectiveratewas57．1％；Throughchi—squaretes